Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 13.5M | 21.5M | 30.1M | 12.3M |
Selling general and admin | 29.3M | 37.3M | 49.2M | 10.9M |
Other operating expenses | — | — | — | — |
Operating income | -42.8M | -58.8M | -79.3M | -23.2M |
Non operating interest income | ||||
Income | 3.3M | 3.4M | 3.6M | 3.0M |
Expense | 1.4M | — | — | — |
Other income expense | -3.0M | -327K | -877K | -1.6M |
Pretax income | -43.8M | -56.0M | -76.6M | -21.9M |
Tax provision | — | — | — | — |
Net income | -43.8M | -56.0M | -76.6M | -21.9M |
Basic EPS | -1.0 | -1.3 | -1.8 | -0.6 |
Diluted EPS | -1.0 | -1.3 | -1.8 | -0.6 |
Basic average shares | 46.2M | 43.9M | 41.9M | 38.6M |
Diluted average shares | 46.2M | 43.9M | 41.9M | 38.6M |
EBITDA | -38.9M | -49.1M | -78.0M | -21.1M |
Net income from continuing op. | -43.8M | -56.0M | -76.6M | -21.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |